184 related articles for article (PubMed ID: 17531480)
1. 2-Cycloalkyl phenoxyacetic acid CRTh2 receptor antagonists.
Sandham DA; Aldcroft C; Baettig U; Barker L; Beer D; Bhalay G; Brown Z; Dubois G; Budd D; Bidlake L; Campbell E; Cox B; Everatt B; Harrison D; Leblanc CJ; Manini J; Profit R; Stringer R; Thompson KS; Turner KL; Tweed MF; Walker C; Watson SJ; Whitebread S; Willis J; Williams G; Wilson C
Bioorg Med Chem Lett; 2007 Aug; 17(15):4347-50. PubMed ID: 17531480
[TBL] [Abstract][Full Text] [Related]
2. 7-Azaindole-3-acetic acid derivatives: potent and selective CRTh2 receptor antagonists.
Sandham DA; Adcock C; Bala K; Barker L; Brown Z; Dubois G; Budd D; Cox B; Fairhurst RA; Furegati M; Leblanc C; Manini J; Profit R; Reilly J; Stringer R; Schmidt A; Turner KL; Watson SJ; Willis J; Williams G; Wilson C
Bioorg Med Chem Lett; 2009 Aug; 19(16):4794-8. PubMed ID: 19592244
[TBL] [Abstract][Full Text] [Related]
3. Novel selective orally active CRTH2 antagonists for allergic inflammation developed from in silico derived hits.
Ulven T; Receveur JM; Grimstrup M; Rist Ø; Frimurer TM; Gerlach LO; Mathiesen JM; Kostenis E; Uller L; Högberg T
J Med Chem; 2006 Nov; 49(23):6638-41. PubMed ID: 17154491
[TBL] [Abstract][Full Text] [Related]
4. Switching between agonists and antagonists at CRTh2 in a series of highly potent and selective biaryl phenoxyacetic acids.
Luker T; Bonnert R; Schmidt J; Sargent C; Paine SW; Thom S; Pairaudeau G; Patel A; Mohammed R; Akam E; Dougall I; Davis AM; Abbott P; Brough S; Millichip I; McInally T
Bioorg Med Chem Lett; 2011 Jun; 21(12):3616-21. PubMed ID: 21592791
[TBL] [Abstract][Full Text] [Related]
5. Thienopyrrole acetic acids as antagonists of the CRTH2 receptor.
Bonafoux D; Abibi A; Bettencourt B; Burchat A; Ericsson A; Harris CM; Kebede T; Morytko M; McPherson M; Wallace G; Wu X
Bioorg Med Chem Lett; 2011 Mar; 21(6):1861-4. PubMed ID: 21316222
[TBL] [Abstract][Full Text] [Related]
6. Indole-3-acetic acid antagonists of the prostaglandin D2 receptor CRTH2.
Armer RE; Ashton MR; Boyd EA; Brennan CJ; Brookfield FA; Gazi L; Gyles SL; Hay PA; Hunter MG; Middlemiss D; Whittaker M; Xue L; Pettipher R
J Med Chem; 2005 Oct; 48(20):6174-7. PubMed ID: 16190744
[TBL] [Abstract][Full Text] [Related]
7. Discovery of potent, selective, and orally bioavailable alkynylphenoxyacetic acid CRTH2 (DP2) receptor antagonists for the treatment of allergic inflammatory diseases.
Crosignani S; Prêtre A; Jorand-Lebrun C; Fraboulet G; Seenisamy J; Augustine JK; Missotten M; Humbert Y; Cleva C; Abla N; Daff H; Schott O; Schneider M; Burgat-Charvillon F; Rivron D; Hamernig I; Arrighi JF; Gaudet M; Zimmerli SC; Juillard P; Johnson Z
J Med Chem; 2011 Oct; 54(20):7299-317. PubMed ID: 21916510
[TBL] [Abstract][Full Text] [Related]
8. Discovery of novel and potent CRTH2 antagonists.
Ito S; Terasaka T; Zenkoh T; Matsuda H; Hayashida H; Nagata H; Imamura Y; Kobayashi M; Takeuchi M; Ohta M
Bioorg Med Chem Lett; 2012 Jan; 22(2):1194-7. PubMed ID: 22178554
[TBL] [Abstract][Full Text] [Related]
9. Tetrahydroquinoline derivatives as CRTH2 antagonists.
Liu J; Wang Y; Sun Y; Marshall D; Miao S; Tonn G; Anders P; Tocker J; Tang HL; Medina J
Bioorg Med Chem Lett; 2009 Dec; 19(24):6840-4. PubMed ID: 19896843
[TBL] [Abstract][Full Text] [Related]
10. Discovery and optimization of a biphenylacetic acid series of prostaglandin D2 receptor DP2 antagonists with efficacy in a murine model of allergic rhinitis.
Scott JM; Baccei C; Bain G; Broadhead A; Evans JF; Fagan P; Hutchinson JH; King C; Lorrain DS; Lee C; Prasit P; Prodanovich P; Santini A; Stearns BA
Bioorg Med Chem Lett; 2011 Nov; 21(21):6608-12. PubMed ID: 21958540
[TBL] [Abstract][Full Text] [Related]
11. Diazine indole acetic acids as potent, selective, and orally bioavailable antagonists of chemoattractant receptor homologous molecule expressed on Th2 cells (CRTH2) for the treatment of allergic inflammatory diseases.
Kaila N; Huang A; Moretto A; Follows B; Janz K; Lowe M; Thomason J; Mansour TS; Hubeau C; Page K; Morgan P; Fish S; Xu X; Williams C; Saiah E
J Med Chem; 2012 Jun; 55(11):5088-109. PubMed ID: 22651823
[TBL] [Abstract][Full Text] [Related]
12. A novel antagonist of prostaglandin D2 blocks the locomotion of eosinophils and basophils.
Royer JF; Schratl P; Carrillo JJ; Jupp R; Barker J; Weyman-Jones C; Beri R; Sargent C; Schmidt JA; Lang-Loidolt D; Heinemann A
Eur J Clin Invest; 2008 Sep; 38(9):663-71. PubMed ID: 18837743
[TBL] [Abstract][Full Text] [Related]
13. On the mechanism of interaction of potent surmountable and insurmountable antagonists with the prostaglandin D2 receptor CRTH2.
Mathiesen JM; Christopoulos A; Ulven T; Royer JF; Campillo M; Heinemann A; Pardo L; Kostenis E
Mol Pharmacol; 2006 Apr; 69(4):1441-53. PubMed ID: 16418339
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin D₂ receptor CRTH2 antagonists for the treatment of inflammatory diseases.
Chen JJ; Budelsky AL
Prog Med Chem; 2011; 50():49-107. PubMed ID: 21315928
[No Abstract] [Full Text] [Related]
15. Inhibitory effect of the 4-aminotetrahydroquinoline derivatives, selective chemoattractant receptor-homologous molecule expressed on T helper 2 cell antagonists, on eosinophil migration induced by prostaglandin D2.
Mimura H; Ikemura T; Kotera O; Sawada M; Tashiro S; Fuse E; Ueno K; Manabe H; Ohshima E; Karasawa A; Miyaji H
J Pharmacol Exp Ther; 2005 Jul; 314(1):244-51. PubMed ID: 15798001
[TBL] [Abstract][Full Text] [Related]
16. Discovery and characterization of NVP-QAV680, a potent and selective CRTh2 receptor antagonist suitable for clinical testing in allergic diseases.
Sandham DA; Arnold N; Aschauer H; Bala K; Barker L; Brown L; Brown Z; Budd D; Cox B; Docx C; Dubois G; Duggan N; England K; Everatt B; Furegati M; Hall E; Kalthoff F; King A; Leblanc CJ; Manini J; Meingassner J; Profit R; Schmidt A; Simmons J; Sohal B; Stringer R; Thomas M; Turner KL; Walker C; Watson SJ; Westwick J; Willis J; Williams G; Wilson C
Bioorg Med Chem; 2013 Nov; 21(21):6582-91. PubMed ID: 24021582
[TBL] [Abstract][Full Text] [Related]
17. Novel 2-(2-(benzylthio)-1H-benzo[d]imidazol-1-yl)acetic acids: discovery and hit-to-lead evolution of a selective CRTh2 receptor antagonist chemotype.
Pothier J; Riederer MA; Peter O; Leroy X; Valdenaire A; Gnerre C; Fretz H
Bioorg Med Chem Lett; 2012 Jul; 22(14):4660-4. PubMed ID: 22726929
[TBL] [Abstract][Full Text] [Related]
18. Identification of a potent and selective synthetic agonist at the CRTH2 receptor.
Gervais FG; Morello JP; Beaulieu C; Sawyer N; Denis D; Greig G; Malebranche AD; O'Neill GP
Mol Pharmacol; 2005 Jun; 67(6):1834-9. PubMed ID: 15755909
[TBL] [Abstract][Full Text] [Related]
19. Sodium [2'-[(cyclopropanecarbonyl-ethyl-amino)-methyl]-4'-(6-ethoxy-pyridin-3-yl)-6-methoxy-biphenyl-3-yl]-acetate (AM432): a potent, selective prostaglandin D2 receptor antagonist.
Stock N; Volkots D; Stebbins K; Broadhead A; Stearns B; Roppe J; Parr T; Baccei C; Bain G; Chapman C; Correa L; Darlington J; King C; Lee C; Lorrain DS; Prodanovich P; Santini A; Evans JF; Hutchinson JH; Prasit P
Bioorg Med Chem Lett; 2011 Feb; 21(3):1036-40. PubMed ID: 21211969
[TBL] [Abstract][Full Text] [Related]
20. 2-(1H-Pyrazol-4-yl)acetic acids as CRTh2 antagonists.
Andrés M; Bravo M; Buil MA; Calbet M; Castro J; Domènech T; Eichhorn P; Ferrer M; Gómez E; Lehner MD; Moreno I; Roberts RS; Sevilla S
Bioorg Med Chem Lett; 2013 Jun; 23(11):3349-53. PubMed ID: 23601708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
